Testosterone replacement therapy can increase circulating endothelial progenitor cell number in men with late onset hypogonadism

Andrology

Volumn 1, Issue 4, 2013, Pages 563-569

  Liao, C H ^a,b   Wu, Y N ^a,b   Lin, F Y ^c   Tsai, W K ^d   Liu, S P ^e   Chiang, H S ^a,b  

^a FU JEN CATHOLIC UNIVERSITY   (Taiwan)

^b FU JEN CATHOLIC UNIVERSITY   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^d MACKAY MEMORIAL HOSPITAL   (Taiwan)

^e NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Circulating endothelial progenitor cells; Endothelial function; Late onset hypogonadism; Testosterone replacement therapy

Indexed keywords

TESTOSTERONE;

ADULT; AGED; ANDROGEN THERAPY; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; ENDOTHELIAL PROGENITOR CELL; FLOW CYTOMETRY; HUMAN; HYPOGONADISM; INTERNATIONAL INDEX OF ERECTILE FUNCTION; MALE; MONOCYTE; OPEN STUDY; POSTMARKETING SURVEILLANCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEXUAL FUNCTION; TESTOSTERONE BLOOD LEVEL; TREATMENT DURATION;

ADMINISTRATION, CUTANEOUS; ADULT; AGE OF ONSET; AGED; BIOLOGICAL MARKERS; CELL COUNT; CHI-SQUARE DISTRIBUTION; ENDOTHELIAL CELLS; FLOW CYTOMETRY; GELS; HORMONE REPLACEMENT THERAPY; HUMANS; HYPOGONADISM; MALE; MIDDLE AGED; PRODUCT SURVEILLANCE, POSTMARKETING; STEM CELLS; TAIWAN; TESTOSTERONE; TIME FACTORS; TREATMENT OUTCOME; UP-REGULATION;

EID: 84879486573     PISSN: 20472919     EISSN: 20472927     Source Type: Journal    
DOI: 10.1111/j.2047-2927.2013.00086.x     Document Type: Article

References (37)

1. Asahara T, Masuda H, Takahashi T, Kalka C, Pastore C, Silver M et al. (1999) Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 85, 221-228.
2. Aversa A, Bruzziches R, Francomano D, Rosano G, Isidori AM, Lenzi A et al. (2010) Effects of testosterone undecanoate on cardiovascular risk factors and atherosclerosis in middle-aged men with late-onset hypogonadism and metabolic syndrome: results from a 24-month, randomized, double-blind, placebo-controlled study. J Sex Med 7, 3495-3503.
3. Bumhakel M, Werner N, Bohm M & Nickening G. (2006) Circulating endothelial progenitor cells correlate with erectile with erectile function in patients with coronary heart disease. Eur Heart J 27, 2184-2188.
4. Castela A, Vendeira P & Costa C. (2011) Testosterone, endothelial health, and erectile function. ISRN Endocrinol 2011, 839149.
5. Chiang HS, Cho SL, Lin YC & Hwang TI. (2009) Testosterone gel monotherapy improves sexual function of hypogonadal men mainly through restoring erection: evaluation by IIEF score. Urology 73, 762-766.
6. Chu K, Jung KH, Lee ST, Park HK, Sinn DI, Kim JM et al. (2008) Circulating endothelial progenitor cells as a new marker of endothelial dysfunction or repair in acute stroke. Stroke 39, 1441-1447.
7. Dimmeler S & Zeiher AM. (2004) Vascular repair by circulating endothelial progenitor cells: the missing link in atherosclerosis? J Mol Med (Berl) 82, 671-677.
8. Fadini GP, Miorin M, Facco M, Bonamico S, Baesso I, Grego F et al. (2005) Circulating endothelial progenitor cells are reduced in peripheral vascular complications of type 2 diabetes mellitus. J Am Coll Cardiol 45, 1449-1457.
9. Florvaag A, Oberle V, Fritzenwanger M, Kretschmar D, Betge S, Goebel B et al. (2012) Testosterone deficiency in male heart failure patients and its effect on endothelial progenitor cells. Aging Male 15, 180-186.
10. Foresta C, Caretta N, Lana A, Cabrelle A, Palù G & Ferlin A. (2005) Circulating endothelial progenitor cells in subjects with erectile dysfunction. Int J Impot Res 17, 288-290.
11. Foresta C, Caretta N, Lana A, De Toni L, Biagioli A, Ferlin A et al. (2006) Reduced number of circulating endothelial progenitor cells in hypogonadal men. J Clin Endocrinol Metab 91, 4599-4602.
12. Foresta C, Zuccarello D, De Toni L, Garolla A, Caretta N & Ferlin A. (2008) Androgens stimulate endothelial progenitor cells through an androgen receptor-mediated pathway. Clin Endocrinol (Oxf) 68, 284-299.
13. Foresta C, Di Mambro A, Caretta N, De Toni L, Zuccarello D & Ferlin A. (2009) Effect of vardenafil on endothelial progenitor cells in hypogonadotrophic hypogonadal patients: role of testosterone treatment. Clin Endocrinol (Oxf) 71, 412-416.
14. Hougaku H, Fleg JL, Najjar SS, Lakatta EG, Harman SM, Blackman MR et al. (2006) Relationship between androgenic hormones and arterial stiffness, based on longitudinal hormone measurements. Am J Physiol Endocrinol Metab 290, E234-E242.
15. Huang PH, Chen YH, Tsai HY, Chen JS, Wu TC, Lin FY et al. (2010) Intake of red wine increases the number and functional capacity of circulating endothelial progenitor cells by enhancing nitric oxide bioavailability. Arterioscler Thromb Vasc Biol 30, 869-877.
16. Jin H, Aiyer A, Su J, Borgstrom P, Stupack D, Friedlander M et al. (2006) A homing mechanism for bone marrow-derived progenitor cell recruitment to the neovasculature. J Clin Invest 116, 652-662.
17. Jones TH. (2007) Testosterone associations with erectile dysfunction, diabetes, and the metabolic syndrome. Eur Urol Suppl 6, 847-857.
18. Jones TH & Saad F. (2009) The effects of testosterone on risk factors for, and the mediators of, the atherosclerotic process. Atherosclerosis 207, 318-327.
19. Jones TH, Arver S, Behre HM, Buvat J, Meuleman E, Moncada I et al. (2011) Testosterone replacement in hypogonadal men with type 2 diabetes and/or metabolic syndrome (the TIMES2 study). Diabetes Care 34, 828-837.
20. Kalinchenko SY, Tishova YA, Mskhalaya GJ, Gooren LJ, Giltay EJ & Saad F. (2010) Effects of testosterone supplementation on markers of the metabolic syndrome and inflammation in hypogonadal men with the metabolic syndrome: the double-blinded placebo-controlled Moscow study. Clin Endocrinol (Oxf) 73, 602-612.
21. Kang SM, Jang Y, Kim JY, Chung N, Cho SY, Chae JS et al. (2002) Effect of oral administration of testosterone on brachial arterial vasoreactivity in men with coronary artery disease. Am J Cardiol 89, 862-864.
22. La Vignera S. (2011) New immunophenotype of circulating endothelial progenitor cells and endothelial microparticles in patients with erectile dysfunction and metabolic syndrome: effects of tadalafil administration. Int Angiol 30, 415-423.
23. La Vignera S, Condorelli R, Vicari E, D'Agata R & Calogero A. (2011a) Original immunophenotype of blood endothelial progenitor cells and microparticles in patients with isolated arterial erectile dysfunction and late onset hypogonadism: effects of androgen replacement therapy. Aging Male 14, 183-189.
24. La Vignera S, Condorelli R, Vicari E, D'Agata R & Calogero A. (2011b) Circulating endothelial progenitor cells and endothelial microparticles in patients with arterial erectile dysfunction and metabolic syndrome. J Androl 33, 202-209.
25. Loomans CJ, de Koning EJ, Staal FJ, Rookmaaker MB, Verseyden C, de Boer HC et al. (2004) Endothelial progenitor cell dysfunction: a novel concept in the pathogenesis of vascular complications of type 1 diabetes. Diabetes 53, 195-199.
26. Nieschlag E, Swerdloff R, Behre HM, Gooren LJ, Kaufman JM, Legros JJ et al. International Society of Andrology; International Society for the Study of the Aging Male; European Association of Urology (2005) Investigation, treatment and monitoring of late-onset hypogonadism in males. ISA, ISSAM, and EAU recommendations. Eur Urol 48, 1-4.
27. Op den Buijs J, Musters M, Verrips T, Post JA, Braam B & van Riel N. (2004) Mathematical modeling of vascular endothelial layer maintenance: the role of endothelial cell division, progenitor cell homing, and telomere shortening. Am J Physiol Heart Circ Physiol 287, H2651-H2658.
28. Rosen RC, Riley A, Wagner G, Osterloh IH, Kirkpatrick J & Mishra A. (1997) The International Index of Erectile Function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology 49, 822-830.
29. Rosen RC, Cappelleri JC & Gendrano N 3rd (2002) The International Index of Erectile Function (IIEF): a state-of-the-science review. Int J Impot Res 14, 226-244.
30. Schmidt-Lucke C, Rössig L, Fichtlscherer S, Vasa M, Britten M, Kämper U et al. (2005) Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: proof of concept for the clinical importance of endogenous vascular repair. Circulation 111, 2981-2987.
31. Schwartz SM & Benditt EP. (1976) Clustering of replicating cells in aortic endothelium. Proc Natl Acad Sci U S A 73, 651-653.
32. Shabsigh R, Rajfer J, Aversa A, Traish AM, Yassin A, Kalinchenko SY et al. (2006) The evolving role of testosterone in the treatment of erectile dysfunction. Int Clin Pract 60, 1087-1092.
33. Shabsigh R, Kaufman JM, Steidle C & Padma-Nathan H. (2008) Randomized study of testosterone gel as adjunctive therapy to sildenafil in hypogonadal men with erectile dysfunction who do not respond to sildenafil alone. J Urol 179, S97-S102.
34. Traish AM, Saad F, Feeley RJ & Guay A. (2009) The dark side of testosterone deficiency: III Cardiovascular disease. J Androl 30, 477-494.
35. Vermeulen A, Verdonck L & Kaufman JM. (1999) A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab 84, 3666-3672.
36. Wald M, Meacham RB, Ross LS & Niederberger CS. (2006) Testosterone replacement therapy for older men. J Androl 27, 126-132.
37. Werner N, Kosiol S, Schiegl T, Ahlers P, Walenta K, Link A et al. (2005) Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med 353, 999-1007.